You are here: Industry Insights > Q BioMed

News List

Q BioMed Technology Partner Mannin Research Enters Into Collaboration With McMaster University for Glaucoma Drug Candidate MAN-01 firstwordpharma
January 28, 2019
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
Q BioMed Announces Partnership with SRI International americanpharmaceuticalreview
December 13, 2018
Q BioMed announced a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001....
Searchlight Pharma, Q BioMed, Quest PharmaTech pharmaceutical-technology
December 03, 2018
Searchlight Pharma has acquired the Canadian marketing rights for Divigel® from Vertical Pharmaceuticals.Divigel® is a prescription transdermal estrogen product ......
Q BioMed Acquires Metastron from GE Healthcare americanpharmaceuticalreview
November 29, 2018
Q BioMed has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron, from GE Healthcare....
Q BioMed to commercialise non-narcotic metastatic cancer pain drug europeanpharmaceuticalreview
June 13, 2017
Q BioMed Inc has initiated production of Strontium-89 Chloride, a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain.

Previous page 1 2 Next page